Serum CRP and IL-6, genetic variants and risk of colorectal adenoma in a multiethnic population

Cancer Causes and Control

Volumn 21, Issue 7, 2010, Pages 1131-1138

  Ognjanovic, Simona ^a,b   Yamamoto, Jennifer ^a   Saltzman, Barbara ^a   Franke, Adrian ^a   Ognjanovic, Miodrag ^b   Yokochi, Lance ^c   Vogt, Thomas ^d   Decker, Robert ^d   Le Marchand, Loïc ^a  

^a UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c PACIFIC HEALTH RESEARCH INSTITUTE   (United States)

^d KAISER PERMANENTE   (United States)

Author keywords

Colorectal adenoma; CRP; IL 6; SNPs

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6;

ADULT; AGED; AGING; ARTICLE; BODY MASS; CANCER RISK; CASE CONTROL STUDY; COLORECTAL ADENOMA; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; GENETIC RISK; GENETIC VARIABILITY; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RACE DIFFERENCE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SIGMOIDOSCOPY; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; UNITED STATES;

ADENOMA; AGE FACTORS; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAWAII; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; OCEANIC ANCESTRY GROUP; POLYMORPHISM, SINGLE NUCLEOTIDE; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; SIGMOIDOSCOPY;

EID: 77955664255     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-010-9540-7     Document Type: Article

References (30)

1. Rhodes JM, Campbell BJ (2002) Inflammation and colorectal cancer: IBD-associated and sporadic cancer compared. Trends Mol Med 8(1):10-16
2. Cesari M, Penninx BW, Pahor M, Lauretani F, Corsi AM, Rhys Williams G et al (2004) Inflammatory markers and physical performance in older persons: the InCHIANTI study. J Gerontol A Biol Sci Med Sci 59(3):242-248
3. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P et al (2000) Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 321(7255):199-204
4. Ferrucci L, Harris TB, Guralnik JM, Tracy RP, Corti MC, Cohen HJ et al (1999) Serum IL-6 level and the development of disability in older persons. J Am Geriatr Soc 47(6):639-646
5. Ito Y, Suzuki K, Tamakoshi K, Wakai K, Kojima M, Ozasa K et al (2005) Colorectal cancer and serum C-reactive protein levels: a case-control study nested in the JACC Study. J Epidemiol 15(Suppl 2):S185-S189
6. Otani T, Iwasaki M, Sasazuki S, Inoue M, Tsugane S (2006) Plasma C-reactive protein and risk of colorectal cancer in a nested case-control study: Japan Public Health Center-based prospective study. Cancer Epidemiol Biomarkers Prev 15(4):690-695
7. Siemes C, Visser LE, Coebergh JW, Splinter TA, Witteman JC, Uitterlinden AG et al (2006) C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study. J Clin Oncol 24(33):5216-5222
8. Trichopoulos D, Psaltopoulou T, Orfanos P, Trichopoulou A, Boffetta P (2006) Plasma C-reactive protein and risk of cancer: a prospective study from Greece. Cancer Epidemiol Biomarkers Prev 15(2):381-384
9. Zhang SM, Buring JE, Lee IM, Cook NR, Ridker PM (2005) C-reactive protein levels are not associated with increased risk for colorectal cancer in women. Ann Intern Med 142(6):425-432
10. Erlinger TP, Platz EA, Rifai N, Helzlsouer KJ (2004) C-reactive protein and the risk of incident colorectal cancer. JAMA 291(5):585-590
11. Gunter MJ, Stolzenberg-Solomon R, Cross AJ, Leitzmann MF, Weinstein S, Wood RJ et al (2006) A prospective study of serum C-reactive protein and colorectal cancer risk in men. Cancer Res 66(4):2483-2487
12. Il'yasova D, Colbert LH, Harris TB, Newman AB, Bauer DC, Satterfield S et al (2005) Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort. Cancer Epidemiol Biomarkers Prev 14(10):2413-2418
13. Kim S, Keku TO, Martin C, Galanko J, Woosley JT, Schroeder JC et al (2008) Circulating levels of inflammatory cytokines and risk of colorectal adenomas. Cancer Res 68(1):323-328
14. Tsilidis KK, Erlinger TP, Rifai N, Hoffman S, Hoffman-Bolton J, Helzlsouer KJ et al (2008) C-reactive protein and colorectal adenoma in the CLUE II cohort. Cancer Causes Control 19(6):559-567
15. Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357(9255):539-545
16. Landi S, Moreno V, Gioia-Patricola L, Guino E, Navarro M, de Oca J et al (2003) Association of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, tumor necrosis factor alpha, NFKB1, and peroxisome proliferator-activated receptor gamma with colorectal cancer. Cancer Res 63(13):3560-3566
17. Theodoropoulos G, Papaconstantinou I, Felekouras E, Nikiteas N, Karakitsos P, Panoussopoulos D et al (2006) Relation between common polymorphisms in genes related to inflammatory response and colorectal cancer. World J Gastroenterol 12(31): 5037-5043
18. Gunter MJ, Canzian F, Landi S, Chanock SJ, Sinha R, Rothman N (2006) Inflammation-related gene polymorphisms and colorectal adenoma. Cancer Epidemiol Biomarkers Prev 15(6): 1126-1131
19. Le Marchand L, Donlon T, Hankin JH, Kolonel LN, Wilkens LR, Seifried A (2002) B-vitamin intake, metabolic genes, and colorectal cancer risk (United States). Cancer Causes Control 13(3):239-248
20. Le Marchand L, Hankin JH, Wilkens LR, Pierce LM, Franke A, Kolonel LN et al (2001) Combined effects of well-done red meat, smoking, and rapid N-acetyltransferase 2 and CYP1A2 phenotypes in increasing colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 10(12):1259-1266
21. Brull DJ, Serrano N, Zito F, Jones L, Montgomery HE, Rumley A et al (2003) Human CRP gene polymorphism influences CRP levels: implications for the prediction and pathogenesis of coronary heart disease. Arterioscler Thromb Vasc Biol 23(11):2063-2069
22. Russell AI, Cunninghame Graham DS, Shepherd C, Roberton CA, Whittaker J, Meeks J et al (2004) Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus. Hum Mol Genet 13(1): 137-147
23. Zee RY, Ridker PM (2002) Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis. Atherosclerosis 162(1): 217-219
24. Salama P, Platell C (2008) Host response to colorectal cancer. ANZ J Surg 78(9):745-753
25. Baquet CR, Commiskey P (1999) Colorectal cancer epidemiology in minorities: a review. J Assoc Acad Minor Phys 10(3): 51-58
26. Chien C, Morimoto LM, Tom J, Li CI (2005) Differences in colorectal carcinoma stage and survival by race and ethnicity. Cancer 104(3):629-639
27. Gershov D, Kim S, Brot N, Elkon KB (2000) C-Reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity. J Exp Med 192(9):1353-1364
28. Baron JA (2003) Epidemiology of non-steroidal anti-inflammatory drugs and cancer. Prog Exp Tumor Res 37:1-24
29. Nakanishi N, Shiraishi T, Wada M (2005) C-reactive protein concentration is more strongly related to metabolic syndrome in women than in men: the Minoh Study. Circ J 69(4):386-391
30. Ockene IS, Matthews CE, Rifai N, Ridker PM, Reed G, Stanek E (2001) Variability and classification accuracy of serial highsensitivity C-reactive protein measurements in healthy adults. Clin Chem 47(3):444-450 1138